Compare RENT & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RENT | LUNG |
|---|---|---|
| Founded | 2009 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.6M | 97.1M |
| IPO Year | 2021 | 2020 |
| Metric | RENT | LUNG |
|---|---|---|
| Price | $2.27 | $1.80 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.40 |
| AVG Volume (30 Days) | 135.9K | ★ 257.4K |
| Earning Date | 12-11-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 110.16 | 7.64 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $329,800,000.00 | $90,497,000.00 |
| Revenue This Year | N/A | $0.06 |
| Revenue Next Year | N/A | $8.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 7.71 | ★ 8.01 |
| 52 Week Low | $1.51 | $1.13 |
| 52 Week High | $10.13 | $2.89 |
| Indicator | RENT | LUNG |
|---|---|---|
| Relative Strength Index (RSI) | 58.11 | 45.11 |
| Support Level | $1.51 | $1.70 |
| Resistance Level | $3.91 | $2.12 |
| Average True Range (ATR) | 0.17 | 0.10 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 86.92 | 39.53 |
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe to, or buy designer apparel and accessories. The company gives customers access to its unlimited closet through its subscription offering (Subscription) or the ability to rent a-la-carte through its reserve offering (Reserve). The company also gives its subscribers and customers the ability to buy its products through its Resale offering. The Closet in the Cloud offers a wide assortment of items for every occasion, from evening wear and accessories to ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear, and ski wear.
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.